365 related articles for article (PubMed ID: 21372296)
21. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules.
Mudaliar H; Pollock C; Komala MG; Chadban S; Wu H; Panchapakesan U
Am J Physiol Renal Physiol; 2013 Jul; 305(2):F143-54. PubMed ID: 23576640
[TBL] [Abstract][Full Text] [Related]
22. Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14.
Kim S; Kim SY; Pribis JP; Lotze M; Mollen KP; Shapiro R; Loughran P; Scott MJ; Billiar TR
Mol Med; 2013 May; 19(1):88-98. PubMed ID: 23508573
[TBL] [Abstract][Full Text] [Related]
23. Neutrophil extracellular trap-microparticle complexes trigger neutrophil recruitment via high-mobility group protein 1 (HMGB1)-toll-like receptors(TLR2)/TLR4 signalling.
Wang Y; Du F; Hawez A; Mörgelin M; Thorlacius H
Br J Pharmacol; 2019 Sep; 176(17):3350-3363. PubMed ID: 31206609
[TBL] [Abstract][Full Text] [Related]
24. Toll-like receptor 4 (TLR4) antagonist eritoran tetrasodium attenuates liver ischemia and reperfusion injury through inhibition of high-mobility group box protein B1 (HMGB1) signaling.
Mcdonald KA; Huang H; Tohme S; Loughran P; Ferrero K; Billiar T; Tsung A
Mol Med; 2015 Mar; 20(1):639-48. PubMed ID: 25375408
[TBL] [Abstract][Full Text] [Related]
25. Protective Effect of TLR4 Ablation against Corneal Neovascularization following Chemical Burn in a Mouse Model.
Friedman M; Azrad-Lebovitz T; Morzaev D; Zahavi A; Marianayagam NJ; Nicholson JD; Brookman M; Michowiz S; Hochhauser E; Goldenberg-Cohen N
Curr Eye Res; 2019 May; 44(5):505-513. PubMed ID: 30595046
[TBL] [Abstract][Full Text] [Related]
26. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro.
Wang FC; Pei JX; Zhu J; Zhou NJ; Liu DS; Xiong HF; Liu XQ; Lin DJ; Xie Y
World J Gastroenterol; 2015 Jul; 21(25):7764-76. PubMed ID: 26167076
[TBL] [Abstract][Full Text] [Related]
28. Critical role of SDF-1α-induced progenitor cell recruitment and macrophage VEGF production in the experimental corneal neovascularization.
Liu G; Lu P; Li L; Jin H; He X; Mukaida N; Zhang X
Mol Vis; 2011; 17():2129-38. PubMed ID: 21850188
[TBL] [Abstract][Full Text] [Related]
29. Activation of Toll-like receptors by Burkholderia pseudomallei.
West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
[TBL] [Abstract][Full Text] [Related]
30. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
Good DW; George T; Watts BA
Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
[TBL] [Abstract][Full Text] [Related]
31. Extracellular high mobility group box-1 (HMGB1) inhibits enterocyte migration via activation of Toll-like receptor-4 and increased cell-matrix adhesiveness.
Dai S; Sodhi C; Cetin S; Richardson W; Branca M; Neal MD; Prindle T; Ma C; Shapiro RA; Li B; Wang JH; Hackam DJ
J Biol Chem; 2010 Feb; 285(7):4995-5002. PubMed ID: 20007974
[TBL] [Abstract][Full Text] [Related]
32. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
[TBL] [Abstract][Full Text] [Related]
33. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products.
Mazarati A; Maroso M; Iori V; Vezzani A; Carli M
Exp Neurol; 2011 Dec; 232(2):143-8. PubMed ID: 21884699
[TBL] [Abstract][Full Text] [Related]
34. Toll-like receptor 4 signaling: A common pathway for interactions between prooxidants and extracellular disulfide high mobility group box 1 (HMGB1) protein-coupled activation.
Zhang Y; Karki R; Igwe OJ
Biochem Pharmacol; 2015 Nov; 98(1):132-43. PubMed ID: 26367307
[TBL] [Abstract][Full Text] [Related]
35. High mobility group box 1/Toll-like receptor danger signaling increases brain neuroimmune activation in alcohol dependence.
Crews FT; Qin L; Sheedy D; Vetreno RP; Zou J
Biol Psychiatry; 2013 Apr; 73(7):602-12. PubMed ID: 23206318
[TBL] [Abstract][Full Text] [Related]
36. Blockade of HMGB1 Attenuates Diabetic Nephropathy in Mice.
Chen X; Ma J; Kwan T; Stribos EGD; Messchendorp AL; Loh YW; Wang X; Paul M; Cunningham EC; Habib M; Alexander IE; Sharland AF; Chadban SJ; Wu H
Sci Rep; 2018 May; 8(1):8319. PubMed ID: 29844451
[TBL] [Abstract][Full Text] [Related]
37. Critical role of TNF-α-induced macrophage VEGF and iNOS production in the experimental corneal neovascularization.
Lu P; Li L; Liu G; Baba T; Ishida Y; Nosaka M; Kondo T; Zhang X; Mukaida N
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3516-26. PubMed ID: 22570350
[TBL] [Abstract][Full Text] [Related]
38. Moraxella catarrhalis activates murine macrophages through multiple toll like receptors and has reduced clearance in lungs from TLR4 mutant mice.
Hassan F; Ren D; Zhang W; Merkel TJ; Gu XX
PLoS One; 2012; 7(5):e37610. PubMed ID: 22662179
[TBL] [Abstract][Full Text] [Related]
39. Anti-High Mobility Group Box 1 Neutralizing-Antibody Ameliorates Dextran Sodium Sulfate Colitis in Mice.
Chen L; Li J; Ye Z; Sun B; Wang L; Chen Y; Han J; Yu M; Wang Y; Zhou Q; Seidler U; Tian D; Xiao F
Front Immunol; 2020; 11():585094. PubMed ID: 33193406
[TBL] [Abstract][Full Text] [Related]
40. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.
Li L; Chen L; Hu L; Liu Y; Sun HY; Tang J; Hou YJ; Chang YX; Tu QQ; Feng GS; Shen F; Wu MC; Wang HY
Hepatology; 2011 Nov; 54(5):1620-30. PubMed ID: 21809356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
